Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Intrauterine Contraceptive Devices Market Size is projected to reach USD 3.95 billion by 2031, growing at a CAGR of 3.5%: Straits Research

Published

1 year ago

on

<!– Name:DistributionId Value:8783309 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value:5557 –> <!– Name:CustomerId Value:1220679 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:e32f6aa6-2cbf-4660-af8a-aa0ab10a23a1 –>

New York, United States, March 07, 2023 (GLOBE NEWSWIRE) — The intrauterine device, or IUD, is a small, T-shaped contraceptive implanted inside the uterus. Such methods of contraception are effective, convenient, and safe. Using an IUD to prevent pregnancy is generally considered safe. To achieve their contraceptive effect, IUDs cause localized inflammation. Chemicals released during the inflammatory response in the uterus are fatal to sperm. There could be repercussions for sperm’s capacity to fertilize eggs. These can be helpful even if you’ve already had an abortion. An intrauterine device is one of the most effective and low-risk ways to prevent pregnancy (IUD). Intrauterine contraceptive devices (IUDs) are medical devices that can prevent pregnancy after they have been implanted. These can last anywhere from three to ten years in length.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/intrauterine-contraceptive-devices-iud-market/request-sample 

An Increase in Awareness of These Devices’ Availability through Campaigns and Digital Advertisements Drives the Global Market

Small T-shaped devices called intrauterine devices (IUDs) are implanted in women’s uteruses to stop pregnancy. Hormonal contraceptives, such as copper IUDs, are very popular. The market for intrauterine contraceptives is growing due to the products’ many positive attributes. Government programs that emphasize the benefits of using IUDs have a significant impact on market demand. Even in developing countries, the need for these tools is the only reason for spreading the word about them. Intrauterine contraceptive devices are experiencing rapid market growth due to increasing demand and continuous innovation’s stimulating effect.

Increasing Inclination towards Planned Delayed Pregnancy Creates Tremendous Opportunities

Growth of the market is expected to be driven by rising demand from women who want to postpone having children voluntarily. The adoption of novel strategies by the United States government to increase access to sexual and reproductive health services and products is expected to increase the number of people interested in delaying pregnancy. In women, intrauterine devices prevent fertility for 3-10 years with a 99% success rate. In many parts of the country, teenage girls are rising. That means more women must have access to and use contraceptives like intrauterine devices to stop unwanted pregnancies and unsafe abortions. It has significant implications, in addition to the high product adoption rates for preventing unintended pregnancies. The far-reaching effects of unintended pregnancies are expected to increase market opportunities for IUDs in the coming years.

Report Scope

Report Metric Details
Market Size USD 3.95 billion by 2031
CAGR 3.5% (2023-2031)
Historical Data 2020-2021
Base Year 2022
Forecast Period 2023-2031
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Type, Product, End-User
Geographies Covered North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors Agile Therapeutics, Bayer Healthcare, Fuji Latex Co. Ltd, Pfizer, Reckitt Benckiser Group PLC, Mylan Laboratories, Merck & Co., and Okamato Industries Inc.
Key Market Opportunities Increasing Inclination towards Planned Delayed Pregnancy
Key Market Drivers An Increase in Awareness of These Devices’ Availability through Campaigns and Digital Advertisements


Buy Now Full Report @ https://straitsresearch.com/buy-now/intrauterine-contraceptive-devices-iud-market

Regional Analysis

Europe is the most significant shareholder in the global intrauterine contraceptive devices market and is expected to grow during the forecast period.   Europe is expected to lead the market for intrauterine contraceptive devices due to the region’s high adoption of IUDs over oral contraceptives. Effective and relatively side-effect-free, intrauterine devices (IUDs) are a popular method of birth control. The fertility rate in Europe is the lowest of any continent. Across the region, the average number of children per family is 1.44. Manufacturers invest heavily in R&D to develop novel products with enhanced efficacy and reduced side effects (R&D). As a result of rising healthcare costs and personal preferences, consumers are increasingly putting off having children, which is expected to boost demand further.

Asia-Pacific is expected to grow during the forecast period. Because Asia and the Pacific have a higher rate of unintended pregnancy, it stands to reason that this region would have a disproportionately large share of the market for intrauterine contraceptive devices. The market expansion is also aided by the growing number of healthcare-related government initiatives in Asia. Government and non-government organizations have made strides in recent years to increase access to intrauterine contraceptive devices to decrease the number of abortions and unintended pregnancies.

There is an expected rise in the North American market for intrauterine contraceptive devices to the position of second largest in the world. Women are becoming increasingly aware of the issue, and IUDs are an effective and long-lasting solution. According to data from the National Center for Health Statistics, long-acting intrauterine devices (IUDs) are women’s most common form of contraception. Because they are one of the most effective forms of reversible contraception, UDs are gaining popularity among women and doctors. The highest levels of demand have been seen in the United States market for both hormone-free copper IUDs and IUDs that use hormones. Many American women use hormonal IUDs; three of the most popular brands are Mirena, Skyla, and Liletta. Patients’ access to IUDs has grown thanks to new recommendations from the American College of Obstetricians and Gynaecologists.

Slow development in LAMEA is likely due to low awareness and unfulfilled demand. The UN report found that 24% of the unmet need was in the countries of sub-Saharan Africa. The unmet need is usually the highest in areas where contraceptive use is low. Furthermore, most Latin American and Caribbean countries had relatively high rates of contraceptive use. The many benefits of intrauterine devices, such as their high efficacy as a method of birth control and their low impact on fertility and menstrual symptoms, have increased in popularity in recent years.

Key Highlights

  • The global intrauterine contraceptive devices market was valued at USD 2.89 billion in 2022. It is projected to reach USD 3.95 billion by 2031, growing at a CAGR of 3.5% during the forecast period (2023–2031).
  • Based on type, the global intrauterine contraceptive devices market is bifurcated into hormonal and copper intrauterine devices. The hormonal intrauterine devices segment is the highest contributor to the market and is expected to grow during the forecast period.
  • Based on product, the global intrauterine contraceptive devices market is bifurcated into Mirena, Skyla, paragard, essure, levosert, and others. The Mirena segment is the highest contributor to the market and is expected to grow during the forecast period.
  • Based on end-user, the global intrauterine contraceptive devices market is bifurcated into hospitals, gynecology clinics, and community healthcare centers. The hospital segment is the highest contributor to the market and is expected to grow during the forecast period.
  • Europe is the most significant shareholder in the global intrauterine contraceptive devices market and is expected to grow during the forecast period. 

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/intrauterine-contraceptive-devices-iud-market/request-sample

Competitors in Intrauterine Contraceptive Devices Market

The global intrauterine contraceptive devices market’s major key players are

  • Agile Therapeutics
  • Bayer Healthcare
  • Fuji Latex Co. Ltd
  • Pfizer
  • Reckitt Benckiser Group PLC
  • Mylan Laboratories
  • Merck & Co.
  • Okamato Industries Inc.

Segmentation of Intrauterine Contraceptive Devices Market

By Type

  • Hormonal Intrauterine Devices
  • Copper Intrauterine Devices

By Product

  • Mirena
  • Skyla
  • Paragard
  • Essure
  • Levosert
  • Others

By End-User

  • Hospitals
  • Gynecology Clinics
  • Community Healthcare Centers

By Regions

  • North America
  • Europe
  • Asia-Pacific
  • LAMEA

Table of Content

  1. Executive Summary
  2. Research Scope & Segmentation
    1. Research Objectives
    2. Market Definition
    3. Limitations & Assumptions
    4. Market Scope & Segmentation
    5. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    4. Investment Landscape
    5. New Business Models / Revenue Streams
    6. TAM
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Human Factors
    6. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    3. Sales And Distribution Channel Analysis
    4. Trade Analysis
    5. Average Pricing Analysis
    6. Patent Analysis
    7. M & A Agreements & Collabration Analysis
    8. Cost Structure Analysis
  6. ESG Trends
  7. Global Intrauterine Contraceptive Devices Market Size Analysis
    1. Global Intrauterine Contraceptive Devices Market Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Hormonal Intrauterine Devices
        1. By Value
      3. Copper Intrauterine Devices
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Mirena
        1. By Value
      3. Skyla
        1. By Value
      4. Paragard
        1. By Value
      5. Essure
        1. By Value
      6. Levosert
        1. By Value
      7. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Gynecology Clinics
        1. By Value
      4. Community Healthcare Centers
        1. By Value
  8. North America Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Hormonal Intrauterine Devices
        1. By Value
      3. Copper Intrauterine Devices
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Mirena
        1. By Value
      3. Skyla
        1. By Value
      4. Paragard
        1. By Value
      5. Essure
        1. By Value
      6. Levosert
        1. By Value
      7. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Gynecology Clinics
        1. By Value
      4. Community Healthcare Centers
        1. By Value
    5. U.S.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Hormonal Intrauterine Devices
          1. By Value
        3. Copper Intrauterine Devices
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Mirena
          1. By Value
        3. Skyla
          1. By Value
        4. Paragard
          1. By Value
        5. Essure
          1. By Value
        6. Levosert
          1. By Value
        7. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Gynecology Clinics
          1. By Value
        4. Community Healthcare Centers
          1. By Value
    6. Canada
  9. Europe Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Hormonal Intrauterine Devices
        1. By Value
      3. Copper Intrauterine Devices
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Mirena
        1. By Value
      3. Skyla
        1. By Value
      4. Paragard
        1. By Value
      5. Essure
        1. By Value
      6. Levosert
        1. By Value
      7. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Gynecology Clinics
        1. By Value
      4. Community Healthcare Centers
        1. By Value
    5. U.K.
      1. By Type
        1. Introduction
          1. Type By Value
        2. Hormonal Intrauterine Devices
          1. By Value
        3. Copper Intrauterine Devices
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Mirena
          1. By Value
        3. Skyla
          1. By Value
        4. Paragard
          1. By Value
        5. Essure
          1. By Value
        6. Levosert
          1. By Value
        7. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Gynecology Clinics
          1. By Value
        4. Community Healthcare Centers
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest Of Europe
  10. APAC Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Hormonal Intrauterine Devices
        1. By Value
      3. Copper Intrauterine Devices
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Mirena
        1. By Value
      3. Skyla
        1. By Value
      4. Paragard
        1. By Value
      5. Essure
        1. By Value
      6. Levosert
        1. By Value
      7. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Gynecology Clinics
        1. By Value
      4. Community Healthcare Centers
        1. By Value
    5. China
      1. By Type
        1. Introduction
          1. Type By Value
        2. Hormonal Intrauterine Devices
          1. By Value
        3. Copper Intrauterine Devices
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Mirena
          1. By Value
        3. Skyla
          1. By Value
        4. Paragard
          1. By Value
        5. Essure
          1. By Value
        6. Levosert
          1. By Value
        7. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Gynecology Clinics
          1. By Value
        4. Community Healthcare Centers
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest Of Asia-Pacific
  11. Middle East And Africa Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Hormonal Intrauterine Devices
        1. By Value
      3. Copper Intrauterine Devices
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Mirena
        1. By Value
      3. Skyla
        1. By Value
      4. Paragard
        1. By Value
      5. Essure
        1. By Value
      6. Levosert
        1. By Value
      7. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Gynecology Clinics
        1. By Value
      4. Community Healthcare Centers
        1. By Value
    5. UAE
      1. By Type
        1. Introduction
          1. Type By Value
        2. Hormonal Intrauterine Devices
          1. By Value
        3. Copper Intrauterine Devices
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Mirena
          1. By Value
        3. Skyla
          1. By Value
        4. Paragard
          1. By Value
        5. Essure
          1. By Value
        6. Levosert
          1. By Value
        7. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Gynecology Clinics
          1. By Value
        4. Community Healthcare Centers
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest Of MEA
  12. LATAM Market Analysis
    1. Introduction
    2. By Type
      1. Introduction
        1. Type By Value
      2. Hormonal Intrauterine Devices
        1. By Value
      3. Copper Intrauterine Devices
        1. By Value
    3. By Product
      1. Introduction
        1. Product By Value
      2. Mirena
        1. By Value
      3. Skyla
        1. By Value
      4. Paragard
        1. By Value
      5. Essure
        1. By Value
      6. Levosert
        1. By Value
      7. Others
        1. By Value
    4. By End-User
      1. Introduction
        1. End-User By Value
      2. Hospitals
        1. By Value
      3. Gynecology Clinics
        1. By Value
      4. Community Healthcare Centers
        1. By Value
    5. Brazil
      1. By Type
        1. Introduction
          1. Type By Value
        2. Hormonal Intrauterine Devices
          1. By Value
        3. Copper Intrauterine Devices
          1. By Value
      2. By Product
        1. Introduction
          1. Product By Value
        2. Mirena
          1. By Value
        3. Skyla
          1. By Value
        4. Paragard
          1. By Value
        5. Essure
          1. By Value
        6. Levosert
          1. By Value
        7. Others
          1. By Value
      3. By End-User
        1. Introduction
          1. End-User By Value
        2. Hospitals
          1. By Value
        3. Gynecology Clinics
          1. By Value
        4. Community Healthcare Centers
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest Of LATAM
  13. Competitive Assessment
    1. Adoption Matrix
    2. Intrauterine Contraceptive Devices Market Share By Manufacturers
    3. Intrauterine Contraceptive Devices Market Ranking By Revenue For Manufacturers
    4. Average Price By Manufacturers
    5. Vendor Footprint Analysis
  14. Market Players Assessment
    1. Agile Therapeutics
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. Gross Margin
      6. Swot Analysis
      7. Recent Developmments
    2. Bayer Healthcare
    3. Fuji Latex Co. Ltd
    4. Pfizer
    5. Reckitt Benckiser Group PLC
    6. Mylan Laboratories
    7. Merck & Co.
    8. Okamato Industries Inc.
  15. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data From Secondary Sources
      2. Primary Data
        1. Key Data From Primary Sources
        2. Breakdown Of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  16. APPENDIX
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  17. DISCLAIMER

Table of Content and Figure @ https://straitsresearch.com/report/intrauterine-contraceptive-devices-iud-market/toc

Recent Development

  • In October 2022, Pfizer Inc. completed its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the developer of NURTEC ODT, a novel migraine therapy approved for both the acute treatment of migraine attacks and their prevention.
  • In September 2022, The CytoReason and Pfizer Collaboration Agreement were expanded to include the Provision of Artificial Intelligence for Drug Discovery and Development.

News Media

Intrauterine Contraceptive Devices (IUD) Market: Blocking Fertilization

Asia-Pacific Region Exhibiting the Fastest Growth in the Global Pregnancy Tracking Application Market

Have a Look at the Related Research Report

Women’s Health Care Market: Information by Drug (Vagifem, Lupron, and Yasmin), Application (Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis), and Regional Insights till Forecast to 2031

Pregnancy Tracking Application Market: Information by Solution (Fertility Tracking), Deployment Type (Android System), Application (Private Users), and Region — Forecast till 2026

Fertility Test Market: Information by Product (Ovulation Prediction Kits, Fertility Monitors), Mode of Purchase (OTC-based, Prescription-based), Application, and Region — Forecast till 2030

Fertility Services Market: Information by Procedure (IVF with Intracytoplasmic Sperm Injection (ICSI), Surrogacy), Service (Fresh Non-Donor, Fresh Donor), and Region — Forecast till 2030

Maternity Wear Market: Information by Product Type (Outerwear, Innerwear, and Nightwear), Distribution Channel (Store-Based Retail, Convenience Stores), and Region — Forecast till 2029

About Straits Research Pvt. Ltd.

StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision-making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 480 7505 (the U.S.)

+91 8087085354 (APAC)

+44 208 068 9665 (the U.K.)

Email: [email protected]

Follow Us: LinkedIn | Facebook | Instagram | Twitter

Related Topics:

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Continue Reading

Artificial Intelligence

Skai positioned as Leader in the 2024 SPARK Matrix for AdTech Platforms by Quadrant Knowledge Solutions

Published

1 hour ago

on

May 2, 2024

By

skai-positioned-as-leader-in-the-2024-spark-matrix-for-adtech-platforms-by-quadrant-knowledge-solutions

The Quadrant Knowledge Solutions SPARK Matrix™ provides competitive analysis & ranking of the leading advertising technology vendors.Skai, with its omnichannel advertising platform, receives strong ratings across the parameters of technology excellence and customer impact.MIDDLETON, Mass., May 2, 2024 /PRNewswire/ — Quadrant Knowledge Solutions announced today that it has named Skai as a 2024 technology Leader in the SPARK Matrix analysis of the global SPARK Matrix™ AdTech Platform 2024 Market.

Quadrant Knowledge Solutions’ AdTech Platform market research includes a detailed global market analysis, competitive landscape, and functional capabilities. It aims to provide strategic information for technology vendors to enhance their understanding of the market and support their growth strategies by evaluating different vendors’ capabilities, competitive differentiation, and market position.
According to Piyush Kumar, Analyst, Quadrant Knowledge Solutions, “Skai’s ad tech platform offers an integrated approach to omnichannel media orchestration. It combines campaign activation and management capabilities with advanced AI-driven insights to help marketers make smarter decisions. The platform is designed to provide marketers with a holistic view of their media across all advertising touchpoints, ensuring that marketers are not just reacting to data, but are proactively leveraging it to make choices that drive results. Skai’s industry-first capabilities empower marketers to maximize every channel they’re utilizing across every campaign lifecycle, while streamlining operational processes and deepening understanding of consumer behavior and campaign performance. This has positioned Skai as the leader in the SPARK Matrix: Ad Tech Platforms, 2024.”
Quote by Skai:
“As walled garden media evolves into a full-funnel, omnichannel approach underpinned by first-party data and AI, it is critical for brands, agencies, and retailers to work with an advertising technology platform that enables decisioning, activation, and optimization solutions across all top performance media channels,” said Gil Sadeh, Chief Growth Officer at Skai. “We are thrilled at the acknowledgment of our leading position in this space, and look forward to continuing to drive growth for our customers and partners.”
For more information about Skai visit here
About Skai
Skai is an omnichannel advertising platform, uniquely enabling brands and agencies to run data-driven programs across walled garden media. It empowers both media leaders and activation teams to drive impactful results from their advertising program with AI-powered decisioning, activation, and optimization solutions. Its partners include Google, Amazon Ads, Microsoft, Walmart Connect, Apple Search Ads, Instacart, Criteo, TikTok, Snap, Pinterest, Meta, and more.
For over a decade, Skai has earned the trust of notable brands such as HP, Doordash, Sony, Philips, and L’Oreal. Renowned for innovation and a values-driven culture, Skai is headquartered in San Francisco and Tel Aviv with eight international locations.
Media Contacts:Media Contact- [email protected] 
About Quadrant Knowledge Solutions
Quadrant Knowledge Solutions is a global advisory and consulting firm focused on helping clients in achieving business transformation goals with Strategic Business and Growth advisory services. At Quadrant Knowledge Solutions, our vision is to become an integral part of our client’s business as a strategic knowledge partner. Our research and consulting deliverables are designed to provide comprehensive information and strategic insights for helping clients formulate growth strategies to survive and thrive in ever-changing business environments.
For more available research, please visit https://quadrant-solutions.com/market-research/ 
Contact:Ajinkya IngleQuadrant Knowledge SolutionsRegus Business Center35 Village Road, Suite 100,Middleton Massachusetts 01949United StatesEmail: [email protected] Phone: (+1) 978-344-2770Content Source: https://quadrant-solutions.com/press-release/skai-positioned-as-leader-in-the-2024-spark-matrix-for-adtech-platforms-by-quadrant-knowledge-solutions-577Connect with us on LinkedIn- https://www.linkedin.com/company/quadrant-knowledge-solutions/
Logo: https://mma.prnewswire.com/media/746706/1470558/Quadrant_Knowledge_Solutions_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/skai-positioned-as-leader-in-the-2024-spark-matrix-for-adtech-platforms-by-quadrant-knowledge-solutions-302134701.html

Continue Reading

Artificial Intelligence

Doosan Robotics to Unveil New, Best-in-Class Cobot at Automate 2024

Published

1 hour ago

on

May 2, 2024

By

doosan-robotics-to-unveil-new,-best-in-class-cobot-at-automate-2024

The Industry-Leading Motion Platform Company will Present Cutting-Edge Products Like the Award-Winning Dart-Suite Robot Ecosystem and an AI-Powered Bartending Cobot “Mixmaster Moodie”
CHICAGO, May 2, 2024 /PRNewswire/ — Doosan Robotics Inc., one of the world’s leading collaborative robot (cobot) manufacturers, is poised to transform the robotics landscape at Automate 2024, North America’s largest automation showcase, with the industry’s latest cobot advancements across various sectors. Doosan Robotics is exhibiting at Automate May 6-9 at McCormick Place booth #850 in Chicago, IL.

With a comprehensive range of cobots and cutting-edge software like Dart-Suite and AI technology, Doosan Robotics is dedicated to revolutionizing motion solutions tailored to human needs. From machine tending to palletizing, welding, and F&B services, the company offers a diverse array of ready-to-sell solutions catered to both domestic and global markets. That is why Doosan Robotics’ theme at this year’s Automate is “The Motion Platform Company.”
On May 6, Doosan Robotics will unveil its latest, never-before-seen industrial cobot which boasts the greatest capabilities of any machine in its category including a 30 kg payload.
Doosan Robotics booth will feature Dart-Suite, a 2024 RBR50* (Robotics Business Review) Innovation Award-winning advanced robot ecosystem designed to redefine the way customers utilize Doosan cobots. The scalable platform elevates cobot capabilities by providing unlimited programmable motions, while ensuring accessibility for all. Dart-Suite fosters a cohesive environment where every component synergizes, empowering users to create, market, download, and activate functions through diverse interfaces. This evolution propels robots from mere static tools to dynamic, flexible collaborators. The Dart-Suite platform has also been honored as a finalist of the 2024 Automate Innovation Awards in the category of Software.
“Our team at Doosan Robotics is honored to return to Automate 2024, the pinnacle event of automation in North America,” expressed William Ryu, CEO, Doosan Robotics. “We’re committed to transforming the robotics landscape and Automate holds immense strategic significance for us, offering a direct gateway to various industries. Our cobot line’s power will be on full display, alongside the customizable functionality and usage that differentiate our technology. We look forward to sharing our innovative solutions and continuing to drive the industry forward.”
While at Automate, drinks are on Doosan! The industry-leading, motion-platform company will showcase “Dr. Presso,” an unmanned modular café equipped with a top-of-the-line coffee machine, and “Mixmaster Moodie,” a bartending cobot powered by Microsoft’s OpenAI. “Mixmaster Moodie” is coupled with “Tetote,” Bridgestone’s soft robot hand powered by bendy rubber artificial muscle that  employs a pioneering cocktail recommendation system to serve a cocktail based on visual and audio cues. Doosan will also present its Training Kit, a certified training equipment which allows users to practice and experience Doosan’s cobot training programs anytime, anywhere.
Doosan Robotics joined forces with prominent global companies, each celebrated for their expertise and dominant presence in the market, to pioneer AI cobot solutions for commercialization. These best-in-class partners in each solution include the Apex Motion Control’s Baker-Bot Quad, a first-of-its-kind modular cake decorating system which consists of individual robotic stations including top and side cake icing, decorative borders, top rosettes, and writing messages and drizzling.
Other partnerships include the Paltz De-palletizing System, a robotic depalletizing work cell with vision from BeRobox with CMES; Ellison Technologies’ AutoPilot Machine Tending Solution which is a load/unload system designed ideally for CNC Machine Tools for the manufacturing industry; the Cloos ArcBot, a Doosan M1013 cobot arm with integrated Cloos StarT welding pack; Hillside Automation’s CNCtender, a Complete Machine Tending solution with software interface on new generation controller; and MARI AARS System which simplifies the deployment, operation, and maintenance of robotic automation systems, marking a groundbreaking advancement in user-friendly AI software and plug-and-play hardware.
Doosan Robotics is driven by a vision to elevate everyday experiences and redefine labor workflows. Their exceptional range of AI cobots is poised to bring about a paradigm shift across various sectors, including manufacturing, logistics, food & beverage, architecture, and service industries. These cutting-edge solutions transcend the constraints of conventional robotics, adeptly maneuvering through intricate scenarios while infusing tasks with enhanced efficiency, safety, and ingenuity. Moreover, the AI system boasts continuous learning capabilities, effortlessly updating its model by autonomously downloading required modules for smooth integration.
Doosan Robotics’ exhibit is located at booth #850 at McCormick Place in Chicago, IL from May 6-9, 2024.
For more information on Doosan Robotics’ Automate 2024 presence, please contact [email protected].
*For more than a dozen years, the RBR50 Robotics Innovation Awards have recognized robots that promise to positively change how we work and live. WTWH Media’s robotics editors select the honorees on the basis of how they address technology and business challenges. The 2024 winners will be celebrated at the inaugural RBR50 Gala at the Robotics Summit & Expo.
ABOUT DOOSAN ROBOTICSDoosan Robotics is a global leader in collaborative robot solutions, embodying the principle of ‘Innovation in every motion, revolutionizing the way we work.’ Doosan robots, known for world-class safety and precision, enhance task efficiency across various sectors from manufacturing to service, enabling people to focus on more valuable work. More information about Doosan Robotics is available at https://www.doosanrobotics.com/en/.
Media ContactR&[email protected]
Photo – https://mma.prnewswire.com/media/2403400/Doosan_Robotics_Cobot.jpgLogo – https://mma.prnewswire.com/media/2403399/Doosan_Robotics_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/doosan-robotics-to-unveil-new-best-in-class-cobot-at-automate-2024-302134140.html

Continue Reading

Artificial Intelligence

AdTheorent named Leader in the 2024 SPARK Matrix for AdTech Platforms by Quadrant Knowledge Solutions

Published

1 hour ago

on

May 2, 2024

By

adtheorent-named-leader-in-the-2024-spark-matrix-for-adtech-platforms-by-quadrant-knowledge-solutions

The Quadrant Knowledge Solutions SPARK Matrix™ provides competitive analysis & ranking of the leading AdTech platform vendors.AdTheorent, with its comprehensive machine learning-powered technology platform, receives strong ratings across the parameters of technology excellence and customer impact.MIDDLETON, Mass., May 2, 2024 /PRNewswire/ — Quadrant Knowledge Solutions announced today that it has named AdTheorent as a 2024 technology Leader in the SPARK Matrix analysis of the global AdTech Platform market.

Quadrant Knowledge Solutions’ AdTech Platform market research includes a detailed global market analysis, competitive landscape, and functional capabilities. It aims to provide strategic information for technology vendors to enhance their understanding of the market and support their growth strategies by evaluating different vendors’ capabilities, competitive differentiation, and market position.
According to Piyush Kumar, Analyst, Quadrant Knowledge Solutions, ‘The AdTheorent platform stands out in the AdTech Platform market due to its advanced machine learning and privacy-forward solutions including its predictive targeting, audience extension solutions, geo-intelligence, and Studio AT creative capability. The platform’s unique features including ID-independent targeting and cross-device mapping help organizations tackle the cookie depreciation challenges, engaging customers across multiple devices, and supporting industry-specific use cases. AdTheorent with its strong partner ecosystem, product strategy & performance, vision, and roadmap has been recognized and is positioned as an emerging leader in SPARK Matrix: AdTech Platform, 2024.’
Quote by AdTheorent:
‘AdTheorent is an ID-independent platform that uses advanced machine learning technology to predict the value of ad impression opportunities based on advertiser goals.  Our unique capabilities have never been more relevant as the digital advertising industry evolves beyond ID-based targeting.  AdTheorent’s 12-year investment in machine-learning innovation positions us and our advertising partners for success in the post-cookie world,” said Jim Lawson, CEO of AdTheorent.  “We are honored to be recognized as a leader in the 2024 Spark Matrix for AdTech Platforms by Quadrant Knowledge Solutions.’
Additional Resources:
For more information about AdTheorent visit here. Complimentary Download – SPARK Matrix™: AdTech PlatformAbout AdTheorent
AdTheorent (Nasdaq: ADTH) uses advanced machine learning technology and privacy-forward solutions to deliver impactful advertising campaigns for marketers. AdTheorent’s machine learning-powered media buying platform powers its predictive targeting, predictive audiences, geo-intelligence, audience extension solutions and in-house creative capability, Studio AT. Leveraging only non-sensitive data and focused on the predictive value of machine learning models, AdTheorent’s product suite and flexible transaction models allow advertisers to identify the most qualified potential consumers coupled with the optimal creative experience to deliver superior results, measured by each advertiser’s real-world business goals.
AdTheorent is consistently recognized with numerous technology, product, growth, and workplace awards.  AdTheorent was named ‘Best Buy-Side Programmatic Platform” in the 2023 Digiday Technology Awards and was honored with an AI Breakthrough Award and “Most Innovative Product” (B.I.G. Innovation Awards) for five consecutive years.  Additionally, AdTheorent is the only seven-time recipient of Frost & Sullivan’s “Digital Advertising Leadership Award.’ AdTheorent is headquartered in New York, with fourteen locations across the United States and Canada.  For more information, visit adtheorent.com.
Media Contacts:
Melanie Berger, [email protected]
About Quadrant Knowledge Solutions
Quadrant Knowledge Solutions is a global advisory and consulting firm focused on helping clients in achieving business transformation goals with Strategic Business and Growth advisory services. At Quadrant Knowledge Solutions, our vision is to become an integral part of our client’s business as a strategic knowledge partner. Our research and consulting deliverables are designed to provide comprehensive information and strategic insights for helping clients formulate growth strategies to survive and thrive in ever-changing business environments.
For more available research, please visit https://quadrant-solutions.com/market-research/ 
Media Contacts:Quadrant Knowledge SolutionsAjinkya IngleQuadrant Knowledge SolutionsRegus Business Center35 Village Road, Suite 100,Middleton Massachusetts 01949United StatesEmail: [email protected] Phone: (+1) 978-344-2770Content Source: https://quadrant-solutions.com/press-release/adtheorent-named-leader-in-the-2024-spark-matrix-for-adtech-platforms-by-quadrant-knowledge-solutions-576Connect with us on LinkedIn- https://www.linkedin.com/company/quadrant-knowledge-solutions/
Logo: https://mma.prnewswire.com/media/746706/1470558/Quadrant_Knowledge_Solutions_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/adtheorent-named-leader-in-the-2024-spark-matrix-for-adtech-platforms-by-quadrant-knowledge-solutions-302134682.html

Continue Reading

Trending